CB

CJNV BioVentures

North America, New York, United States, New York

Description

CJNV BioVentures is a venture capital firm

Investor Profile

CJNV BioVentures has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Health Care
  • Oncology
  • Pharmaceutical
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CJNV BioVentures frequently co-invest with?

Zetta Venture Partners
North America, California, United States, San Francisco
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 2
11.2 Capital
North America, California, United States, San Francisco
Co-Investments: 1
EPIC Ventures
North America, Utah, United States, Salt Lake City
Co-Investments: 1
Hummingbird Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Watermael-boitsfort
Co-Investments: 1
BioTrack Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
North South Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Blackbird Ventures
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
IV
North America, Utah, United States, Salt Lake City
Co-Investments: 1
DCVC
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does CJNV BioVentures often collaborate with?

CG
North America, Utah, United States, Salt Lake City
Shared Deals: 1
MS
North America, Utah, United States, Salt Lake City
Shared Deals: 1
VC
North America, Colorado, United States, Boulder
Shared Deals: 1
CK
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by CJNV BioVentures?

OnCusp Therapeutics

New York, New York, United States

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

BiotechnologyHealth CareOncologyPharmaceuticalProduct Research
Series AJan 4, 2024
Amount Raised: $100,000,000
Noetik

South San Francisco, California, United States

Noetik is an AI-native biotechnology company.

BiotechnologyLife Science
SeedSep 7, 2023
Amount Raised: $14,000,000